http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-30160-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-10
filingDate 2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cac38668bec1ffda1289ed3be75278a
publicationDate 2007-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-30160-A1
titleOfInvention USE OF HETEROCICLIC SULFAMIDE DERIVATIVES FUSED WITH BENZO FOR MIGRANE TREATMENT
abstract The present invention relates to a method for the treatment or prevention of migraine which comprises administering to a subject in need a therapeutically effective amount of one or more novel derivatives of benzo-fused heterocyclic sulfamide of the formula (I) and formula ( II) as defined in this invention. The present invention relates to a method for the treatment and / or prevention of migraine, which includes monotherapy and alternatively, therapy with at least one antimigrane agent.
priorityDate 2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82267

Total number of triples: 19.